ONO-4059

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ONO-4059, covering 2025-06-03 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: ONO-4059 Study in Patients With Steroid-resistant Pemphigus [Phase 3]